Exact Mass: 466.1592
Exact Mass Matches: 466.1592
Found 169 metabolites which its exact mass value is equals to given mass value 466.1592
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Spirapril
Spirapril is an ACE inhibitor antihypertensive drug used to treat hypertension. Like many ACE inhibitors, this is a prodrug which is converted to the active metabolite spiraprilat following oral administration. ACE inhibitors are used primarily in treatment of hypertension and congestive heart failure. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Polystachin (flavone)
rel-(2R,3S)-3-hydroxymethyl-9-methoxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-2,3,6,7-tetrahydrophenanthro[4,3-b]furan-5,11-diol
3,3-Bis(hydroxymethyl)-4,4,8,8-tetramethoxy-2,2-binaphthalene-1,1-diol
2-Hydroxy-5-[(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy]-4,6-dimethylbenzoic acid 3-hydroxy-2,5-dimethylphenyl ester
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)hexan-1-imine
N-(beta-D-glucosyl)-(indol-3-yl)acetyl-L-glutamate
Ala Asp Met Met
Ala Met Asp Met
Ala Met Met Asp
Cys Cys Glu Ile
Cys Cys Glu Leu
Cys Cys Ile Glu
Cys Cys Lys Asn
Cys Cys Leu Glu
Cys Cys Asn Lys
Cys Asp Met Val
Cys Asp Val Met
Cys Glu Cys Ile
Cys Glu Cys Leu
Cys Glu Ile Cys
Cys Glu Leu Cys
Cys Ile Cys Glu
Cys Ile Glu Cys
Cys Lys Cys Asn
Cys Lys Asn Cys
Cys Leu Cys Glu
Cys Leu Glu Cys
Cys Met Asp Val
Cys Met Val Asp
Cys Asn Cys Lys
Cys Asn Lys Cys
Cys Val Asp Met
Cys Val Met Asp
Asp Ala Met Met
Asp Cys Met Val
Asp Cys Val Met
Asp Met Ala Met
Asp Met Cys Val
Asp Met Met Ala
Asp Met Val Cys
Asp Val Cys Met
Asp Val Met Cys
Glu Cys Cys Ile
Glu Cys Cys Leu
Glu Cys Ile Cys
Glu Cys Leu Cys
Glu Gly Met Met
Glu Ile Cys Cys
Glu Leu Cys Cys
Glu Met Gly Met
Glu Met Met Gly
Gly Glu Met Met
Gly Met Glu Met
Gly Met Met Glu
Ile Cys Cys Glu
Ile Cys Glu Cys
Ile Glu Cys Cys
Lys Cys Cys Asn
Lys Cys Asn Cys
Lys Asn Cys Cys
Leu Cys Cys Glu
Leu Cys Glu Cys
Leu Glu Cys Cys
Met Ala Asp Met
Met Ala Met Asp
Met Cys Asp Val
Met Cys Val Asp
Met Asp Ala Met
Met Asp Cys Val
Met Asp Met Ala
Met Asp Val Cys
Met Glu Gly Met
Met Glu Met Gly
Met Gly Glu Met
Met Gly Met Glu
Met Met Ala Asp
Met Met Asp Ala
Met Met Glu Gly
Met Met Gly Glu
Met Val Cys Asp
Met Val Asp Cys
Asn Cys Cys Lys
Asn Cys Lys Cys
Asn Lys Cys Cys
Val Cys Asp Met
Val Cys Met Asp
Val Asp Cys Met
Val Asp Met Cys
Val Met Cys Asp
Val Met Asp Cys
Spirapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
N-[4-(Trifluoromethyl)phenyl]-N-[1-[5-(Trifluoromethyl)pyridin-2-Yl]piperidin-4-Yl]pyridin-3-Amine
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(E)-N-hydroxy-C-(5-methylsulfanylpentyl)carbonimidoyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
N-[[1-(beta-D-Glucopyranosyl)-1H-indole-3-yl]acetyl]-L-glutamic acid
6-(3-cyclopentyloxy-4-methoxyphenyl)-3-(2,5-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
N-[(4-chlorophenyl)methyl]-2-[(1S,4S,6E,12R)-3,10-dioxo-2-oxa-11-azatricyclo[10.7.0.013,18]nonadeca-6,13,15,17-tetraen-4-yl]acetamide
2,3-bis(2-furanyl)-N-[4-(4-morpholinyl)phenyl]-6-quinoxalinecarboxamide
2-(4-benzoylphenoxy)-N-[4-(propan-2-ylsulfamoyl)phenyl]propanamide
N-[2-[[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]-(thiophen-2-ylmethyl)amino]-2-oxoethyl]-2-furancarboxamide
2-(1,3-dimethyl-2,6-dioxo-9-purinyl)-N-[2-(4-morpholinyl)-5-(trifluoromethyl)phenyl]acetamide
N-[9-(2-carboxyethyl)-6-(ethylamino)-2,7-dimethyl-3H-xanthen-3-ylidene]ethanaminium perchlorate
gammaGluCys(4MeOI3M)Gly
A tripeptide that is glutathione in which the side-chain thiol group of the cysteine residue is substituted by a 4-methoxyindol-3-ylmethyl group.
[3-Acetyl-2-methyl-1-(4-methylphenyl)indol-5-yl] 2-(1,3-dioxoisoindol-2-yl)acetate
N-[(3-fluorophenyl)methyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]oxan-2-yl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]oxan-2-yl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
4-(2,8-Dimethylimidazo[1,2-a]pyridine-3-carbonyl)-1-(2-morpholin-4-ylethyl)-5-thiophen-2-ylpyrrolidine-2,3-dione
L-gamma-glutamyl-S-[N-hydroxy-6-(methylsulfanyl)hexanimidoyl]-L-cysteinylglycine
S-(6-methylthiohexylhydroximoyl)glutathione
An S-substituted glutathione in which the thiol hydrogen of glutathoine has been replaced by a 6-methylthiohexylhydroximoyl group.
(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-methoxy-1h-indol-3-yl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid
18-methoxy-13,14-dimethyl-19,20-dioxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4(21),5(9),10,15,17-pentaen-12-yl 2-methylbut-2-enoate
4-({4'-hydroxy-3-[2-(4-hydroxyphenyl)ethynyl]-[1,1'-biphenyl]-2-yl}(phenyl)methylidene)cyclohexa-2,5-dien-1-one
3-hydroxy-2,5-dimethylphenyl 3-(2,4-dihydroxy-3,6-dimethylbenzoyloxy)-6-hydroxy-2,4-dimethylbenzoate
(2r*,3s*)-3-hydroxymethyl-9-methoxy-2-(4'-hydroxy-3',5'-dimethoxyphenyl)-2,3,6,7-tetrahydrophenanthro[4,3-b]furan-5,11-diol
{"Ingredient_id": "HBIN006472","Ingredient_name": "(2r*,3s*)-3-hydroxymethyl-9-methoxy-2-(4'-hydroxy-3',5'-dimethoxyphenyl)-2,3,6,7-tetrahydrophenanthro[4,3-b]furan-5,11-diol","Alias": "NA","Ingredient_formula": "C26H26O8","Ingredient_Smile": "COC1=CC(=C2C(=C1)CCC3=C(C=C4C(C(OC4=C32)C5=CC(=C(C(=C5)OC)O)OC)CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10503","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}